Abcellera Biologics Inc. Aktie
2,34 €
Deine Einschätzung
Abcellera Biologics Inc. Aktie
Was spricht für und gegen Abcellera Biologics Inc. in den nächsten Jahren?
Pro
Kontra
Kommentare
News
![AbCellera Reports Q2 2024 Business Results: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=de)
AbCellera Reports Q2 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
![AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=de)
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies for programs in immunology
![AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=de)
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)